The present study was conducted to elucidate usefulness of newly developed albumin–bilirubin (ALBI) score as alternative methods of BTR for predicting amino acid imbalance that affects prognosis in naïve hepatocellular carcinoma (HCC) patients. Here, ALB is linked to hepatocellular carcinoma.